Rights and permissions
About this article
Cite this article
Rosiglitazone CV risk relative to metformin, sulfonylurea. Inpharma Wkly. 1597, 21 (2007). https://doi.org/10.2165/00128413-200715970-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715970-00047